Statistical methods for comparative treatment effectiveness using claims data
Statistical methods for comparative treatment effectiveness using claims data
批准号:
8037531
负责人:
PINGSHENG WU
金额:
$87.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-27 至 2013-08-31
关键词:
AddressAgonistAntidepressive AgentsAsthmaBenefits and RisksCharacteristicsChildClinicalDataData SetDoseEquilibriumEventFaceInvestigationLifeMethodsModelingNatureObservational StudyOutcomePatientsPerformancePerinatalPharmaceutical PreparationsPhysiciansPregnancyProbabilityPublic HealthResearchResearch DesignResearch PersonnelRiskSafetyScoring MethodSimulateStatistical MethodsStatistical ModelsTechniquesTimeTreatment EffectivenessWorkadverse outcomeanalytical methodcomparativecomparative effectivenesscomparison groupeffectiveness researchexperienceimprovedinsightresearch studyresponsesimulationtheoriestherapy durationtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Significance. Propensity score methods with a dichotomous treatment (exposed v. unexposed) have been extensively evaluated and proven to be an effective tool for reducing bias and balancing the distribution of confounders between comparison groups in observational studies. Propensity score methods to handle multi- level exposure, with and without ordering, and continuous exposures have been developed. However, there is very limited experience in the application of these methods in either simulated or empirical studies. Important information in establishing both the benefits and risks of medications includes the estimation of a dose effect, duration effect, and multiple medication effect in comparative effectiveness and safety investigations. Real- world medication use involves all three of these issues, and researchers need a thoroughly evaluated analytical method to apply in such scenarios. We will determine the generalizability and practical insight of the performance of propensity scores when considering these three important issues: medication dose, multiple medications, and continuous duration of therapy. This project addresses an important gap in the current analytical approach to evaluating the comparative effectiveness of medications, and will enhance and improve the quality of observational comparative effectiveness research. Specific Aims. We will (1) Evaluate the performance of propensity scores when considering a dose-response relationship of medication exposure and the effects of multiple medication exposures; and (2) Evaluate the performance of propensity scores when considering the effects of continuously varying duration of therapy. Research Design. We will conduct both simulation studies and analyses of real data to answer comparative effectiveness research questions for both specific aims. A propensity score is defined as the conditional probability that a patient receives a particular treatment given all her/his other observed covariates. Such treatment can vary with respect to type, dose, and duration of therapy. Appropriate statistical models will be used to estimate this probability for each subject according to the nature of her/his exposure. Dose and duration effects, and difference in effect among medications will be further estimated. Performance of four common applications of propensity scores and four scenarios for which propensity scores are often applied will be evaluated. Results will be further compared with results from conventional multivariable regression models. Impact. The project will address critically important issues encountered in observational comparative effective research. It will have a wide public health impact by providing researchers with a thoroughly evaluated analytical approach to conduct such studies, and will enhance and improve the quality of observational comparative effectiveness research. .
PUBLIC HEALTH RELEVANCE: This project will provide a critically needed and thoroughly evaluated statistical technique to conduct comparative effectiveness research studies using observational data. We will evaluate the application of propensity score methods to common situations when medication dose effect, duration effect, and multiple medication exposures need to be considered. This project addresses an important gap in the current analytical approach to medication comparative effectiveness, and will enhance and improve the quality of observational comparative effectiveness research, and thus have a wide public health impact.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Electronic cigarette use during pregnancy and the impact on newborn metabolic profile and perinatal health outcomes
-
批准号:10220499
-
项目类别:
-
资助金额:$21.67万
-
财政年份:2021
-
负责人:PINGSHENG WU
-
依托单位:
Electronic cigarette use during pregnancy and the impact on newborn metabolic profile and perinatal health outcomes
-
批准号:10395595
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2021
-
负责人:PINGSHENG WU
-
依托单位:
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome
-
批准号:10398259
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2019
-
负责人:PINGSHENG WU
-
依托单位:
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome
-
批准号:10552583
-
项目类别:
-
资助金额:$45.12万
-
财政年份:2019
-
负责人:PINGSHENG WU
-
依托单位:
Antibiotic timing, spectrum, and cumulative dose during pregnancy and infancy on risk of asthma
-
批准号:9170444
-
项目类别:
-
资助金额:$11.85万
-
财政年份:2016
-
负责人:PINGSHENG WU
-
依托单位:
RSV immunoprophylaxis impact on RSV morbidity & asthma in healthy preterm infants
-
批准号:8757597
-
项目类别:
-
资助金额:$13.14万
-
财政年份:2014
-
负责人:PINGSHENG WU
-
依托单位:
RSV immunoprophylaxis impact on RSV morbidity & asthma in healthy preterm infants
-
批准号:8901292
-
项目类别:
-
资助金额:$0.42万
-
财政年份:2014
-
负责人:PINGSHENG WU
-
依托单位:
Real-world patient responsiveness & safety of long-acting beta agonists in asthma
-
批准号:8641889
-
项目类别:
-
资助金额:$97.1万
-
财政年份:2013
-
负责人:PINGSHENG WU
-
依托单位:
Real-world patient responsiveness & safety of long-acting beta agonists in asthma
-
批准号:9294369
-
项目类别:
-
资助金额:$63.46万
-
财政年份:2013
-
负责人:PINGSHENG WU
-
依托单位:
Infant Viral Exposure and Risk of Childhood Asthma
-
批准号:7273665
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2006
-
负责人:PINGSHENG WU
-
依托单位:
Infant Viral Exposure and Risk of Childhood Asthma
-
批准号:7156469
-
项目类别:
-
资助金额:$5.09万
-
财政年份:2006
-
负责人:PINGSHENG WU
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: